Janux Therapeutics
Janux Therapeutics is looking for a Director of FP&A to serve as a strategic finance partner within their clinical organization. The role involves leading budgeting, forecasting, long-range planning, and ensuring the integrity of financial systems and models in a biotech or life sciences environment.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2017
Janux Therapeutics is a biotechnology company developing precision‑engineered T cell immunotherapies. They design novel therapeutics that selectively modulate T cells to treat cancer and autoimmune diseases while minimizing systemic safety issues. Their approach focuses on targeted modulation of immune responses to improve efficacy and reduce toxicity. Janux aims to translate selective T‑cell control into safer, more effective immunotherapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Janux Therapeutics.
Janux Therapeutics, Bristol Myers enter up to $850 million deal to develop cancer drug
1 month ago
Senior Director, Financial Planning & Analysis
City Therapeutics
Financial Planning & Analysis Manager
LegalShield
Director, Divisional Financial Planning & Analysis (FP&A)
Loenbro
Financial Planning & Analysis Manager
Wonderful
Director, Financial Planning & Analysis (Biotech Experience Necessary)
Antares Therapeutics
FP&A Manager
Vertafore